Business Wire

Sonar Launches SonarQube 9.9 LTS to Help Organizations Achieve a State of Clean Code

7.2.2023 14:00:00 EET | Business Wire | Press release

Share

SonarSource, the leading provider of Clean Code solution, today launched SonarQube 9.9 Long-Term Support (LTS). The new release empowers organizations to achieve the Clean Code state quickly, securely, and at scale. With accelerated pull request analysis, support for building and deploying secure cloud-native applications, sophisticated enterprise-grade capabilities, and many innovations related to the detection engine and contextual education, SonarQube 9.9 LTS supercharges organizations to deliver new business value and keep their software a long-term asset.

“Sonar has greatly helped us benchmark and standardize the quality of our codebase - and the LTS makes it much easier for us to deliver Clean Code. The integration with Azure DevOps from a project-to-project perspective as well as the token lifecycle management will be greatly appreciated by our admins and will help streamline our process,” said Stefan Euripidou, Enterprise Architect for DevOps and CICD at Vodafone Group.

Clean Code is essential for every organization competing in today’s digital-driven economy. Poor quality software costs businesses over $2 trillion a year in the US alone, hampering service quality, brand reputation, worker productivity, and employee retention. Code is the difference between good and bad software. Sonar’s latest 9.9 LTS release introduces key capabilities to enable enterprises to build better software in a sustained manner.

“Our mission is to equip organizations with the solution and methodology to achieve a state of Clean Code, making all code fit for development and production. When companies embrace Clean Code practices, they can derive more from their software, minimize risks, and ensure that their software continues to stay valuable,” said Olivier Gaudin, Founder and CEO of SonarSource. “SonarQube 9.9 LTS was designed to not only provide immediate value to our users for their current development but to steadily drive organizations toward a state of Clean Code in a way that’s predictable, reliable, and sustainable.”

Key release innovations

Pull Request Analyzed in Minutes

SonarQube 9.9 LTS provides a significant speed boost for Pull Request (PR) analysis. PRs are now analyzed more than twice as fast, while still providing the same high-precision results. With the implementation of incremental analysis and server-side caching, analysis is more efficient. As developers write and commit code, Pull Request analysis is an important step in merging new code changes to the main branch. Faster analysis means a more efficient software development lifecycle, as developers spend less time waiting and more time delivering business critical features.

Secure Cloud Native Applications

As applications move to the cloud, organizations must ensure the security of not only the source code, but also their configuration files and deployments. SonarQube 9.9 LTS delivers in-depth analysis capabilities to detect ‘secrets’ in code, bad practices, and vulnerabilities so that developers can build and deploy secure cloud native applications. The release adds support for major cloud providers – AWS, Google Cloud, Microsoft Azure, and their underlying technologies – serverless and SAM frameworks, AWS Cloud Development Kit, Infrastructure-as-Code tools (Terraform and Cloudformation), and containerization tools with Kubernetes and Docker. With these additions, organizations can be sure that their cloud native apps are as secure as their traditional on-prem apps.

Enterprise-grade features for Coding at Scale

SonarQube 9.9 LTS introduces stronger access management, administration, governance, and reporting capabilities, enabling organizations to better manage the security and administration of their SonarQube instance and their portfolio of code assets. Chief among these new features are advanced security and compliance reporting, project and portfolio reporting, secure token handling, SCIM integration for user management, and more. Customers using the Data Center Edition can now deploy SonarQube clusters with Kubernetes. Together, these reporting, authentication and operational improvements make it easier to use, secure, and manage SonarQube instances than ever before.

“The latest SonarQube release introduces a variety of critical new features. Not only will we benefit from the new Terraform scan support, but we will also use the enhanced reporting and administration capabilities to strengthen our Quality Gates and streamline communication efforts,” said Vojtech Varga, Service Manager at Siemens AG. “Sonar’s LTS is an opportunity for us to access the latest fixes and features to ensure that we continue to operate with the highest-quality code.”

Increased Detection of all Issue Types; Rich Educational Guidance

Continued innovation in the detection engine allows for improved precision, speed, accuracy, and coverage of all issue types. Users can find and fix more issues in their code. And this LTS release brings in rich educational content to make taint analysis rules easy to understand and contextual to the users’ code and framework – continuing the advancement of the company’s education initiative.

Clean as You Code, the Sustainable Approach to Clean Code

Sonar is a strong proponent of deploying compliant quality gates that will progressively drive organizations to reach a state of Clean Code. This LTS release adds enhancements to the quality gate user experience to help everyone implement and practice Clean as You Code. Quality gates that are not compliant with this methodology can be easily identified and updated.

SonarQube 9.9 LTS is now available for everyone. Read more in the full release announcement and download the LTS for your edition here.

About SonarSource

Sonar empowers developers and organizations to systematically achieve a state of Clean Code so that all code is fit for development and production. By applying the Sonar Clean as You Code methodology, organizations minimize risk, reduce technical debt, and derive more value from their software in a predictable and sustainable way.

The open source and commercial Sonar solution – SonarLint, SonarCloud, and SonarQube – supports over 30 programming languages, frameworks, and infrastructure technologies. Trusted by more than 400,000 organizations globally to clean more than half a trillion lines of code, Sonar is integral to delivering better software.

To learn more about SonarSource, please visit https://www.sonarsource.com/company/about/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact
Jordan Tewell
10Fold for SonarSource
415-666-6066
sonarsource@10fold.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye